title: Induction therapy with rabbit antithymocyte sera reduces rejection episodes in immunologically low-risk living donor renal transplant recipients.
authors.affiliation: Division of Nephrology, Toronto Hospital, Ontario, Canada.
authors.forename: C J
authors.initials: CJ
authors.lastname: Cardella
authors.forename: D
authors.initials: D
authors.lastname: Cattran
authors.forename: S A
authors.initials: SA
authors.lastname: Fenton
authors.forename: S
authors.initials: S
authors.lastname: Albert
authors.forename: M
authors.initials: M
authors.lastname: Robinette
authors.forename: E
authors.initials: E
authors.lastname: Cole
mesh_terms: D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D011817:Rabbits; D016019:Survival Analysis
chemical_list: D000961:Antilymphocyte Serum